1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Allogeneic
1.2.3 Autologous
1.2.4 Viral Vector
1.3 Market by Application
1.3.1 Global Cell and Gene Therapy Manufacturing Services Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology Diseases
1.3.3 Cardiovascular Diseases
1.3.4 Orthopedic Diseases
1.3.5 Ophthalmology Diseases
1.3.6 Infectious Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Manufacturing Services Market Perspective (2017-2028)
2.2 Cell and Gene Therapy Manufacturing Services Growth Trends by Region
2.2.1 Cell and Gene Therapy Manufacturing Services Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell and Gene Therapy Manufacturing Services Historic Market Size by Region (2017-2022)
2.2.3 Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Region (2023-2028)
2.3 Cell and Gene Therapy Manufacturing Services Market Dynamics
2.3.1 Cell and Gene Therapy Manufacturing Services Industry Trends
2.3.2 Cell and Gene Therapy Manufacturing Services Market Drivers
2.3.3 Cell and Gene Therapy Manufacturing Services Market Challenges
2.3.4 Cell and Gene Therapy Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Manufacturing Services Players by Revenue (2017-2022)
3.1.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Players (2017-2022)
3.2 Global Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell and Gene Therapy Manufacturing Services Revenue
3.4 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Manufacturing Services Revenue in 2021
3.5 Cell and Gene Therapy Manufacturing Services Key Players Head office and Area Served
3.6 Key Players Cell and Gene Therapy Manufacturing Services Product Solution and Service
3.7 Date of Enter into Cell and Gene Therapy Manufacturing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Gene Therapy Manufacturing Services Breakdown Data by Type
4.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Type (2017-2022)
4.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Type (2023-2028)
5 Cell and Gene Therapy Manufacturing Services Breakdown Data by Application
5.1 Global Cell and Gene Therapy Manufacturing Services Historic Market Size by Application (2017-2022)
5.2 Global Cell and Gene Therapy Manufacturing Services Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
6.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type
6.2.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
6.2.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
6.2.3 North America Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
6.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Application
6.3.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
6.3.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
6.3.3 North America Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
6.4 North America Cell and Gene Therapy Manufacturing Services Market Size by Country
6.4.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
6.4.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
7.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type
7.2.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
7.2.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
7.2.3 Europe Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
7.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application
7.3.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
7.3.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
7.3.3 Europe Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
7.4 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country
7.4.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
7.4.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type
8.2.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application
8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
8.4 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region
8.4.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
9.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type
9.2.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
9.2.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
9.2.3 Latin America Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
9.3 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application
9.3.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
9.3.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
9.3.3 Latin America Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
9.4 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country
9.4.1 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
9.4.2 Latin America Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size (2017-2028)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type
10.2.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Share by Type (2017-2028)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application
10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Share by Application (2017-2028)
10.4 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country
10.4.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Introduction
11.2.4 Merck KGaA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.2.5 Merck KGaA Recent Developments
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Introduction
11.3.4 Charles River Laboratories Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.3.5 Charles River Laboratories Recent Developments
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Cell and Gene Therapy Manufacturing Services Introduction
11.4.4 Lonza Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.4.5 Lonza Recent Developments
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent Cell and Gene Therapy Manufacturing Services Introduction
11.5.4 Catalent Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.5.5 Catalent Recent Developments
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Introduction
11.6.4 WuXi AppTec Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.6.5 WuXi AppTec Recent Developments
11.7 Takara Bio Inc
11.7.1 Takara Bio Inc Company Details
11.7.2 Takara Bio Inc Business Overview
11.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Introduction
11.7.4 Takara Bio Inc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.7.5 Takara Bio Inc Recent Developments
11.8 Nikon Corporation
11.8.1 Nikon Corporation Company Details
11.8.2 Nikon Corporation Business Overview
11.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.8.4 Nikon Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.8.5 Nikon Corporation Recent Developments
11.9 FUJIFILM Holdings Corporation
11.9.1 FUJIFILM Holdings Corporation Company Details
11.9.2 FUJIFILM Holdings Corporation Business Overview
11.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Introduction
11.9.4 FUJIFILM Holdings Corporation Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.9.5 FUJIFILM Holdings Corporation Recent Developments
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.10.5 F. Hoffmann-La Roche Recent Developments
11.11 Oxford Biomedica Plc
11.11.1 Oxford Biomedica Plc Company Details
11.11.2 Oxford Biomedica Plc Business Overview
11.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Introduction
11.11.4 Oxford Biomedica Plc Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.11.5 Oxford Biomedica Plc Recent Developments
11.12 Cell and Gene Therapy Catapult
11.12.1 Cell and Gene Therapy Catapult Company Details
11.12.2 Cell and Gene Therapy Catapult Business Overview
11.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Introduction
11.12.4 Cell and Gene Therapy Catapult Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.12.5 Cell and Gene Therapy Catapult Recent Developments
11.13 The Discovery Labs LLC
11.13.1 The Discovery Labs LLC Company Details
11.13.2 The Discovery Labs LLC Business Overview
11.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Introduction
11.13.4 The Discovery Labs LLC Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.13.5 The Discovery Labs LLC Recent Developments
11.14 RoslinCT
11.14.1 RoslinCT Company Details
11.14.2 RoslinCT Business Overview
11.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Introduction
11.14.4 RoslinCT Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.14.5 RoslinCT Recent Developments
11.15 JRS PHARMA
11.15.1 JRS PHARMA Company Details
11.15.2 JRS PHARMA Business Overview
11.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Introduction
11.15.4 JRS PHARMA Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.15.5 JRS PHARMA Recent Developments
11.16 FinVector
11.16.1 FinVector Company Details
11.16.2 FinVector Business Overview
11.16.3 FinVector Cell and Gene Therapy Manufacturing Services Introduction
11.16.4 FinVector Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.16.5 FinVector Recent Developments
11.17 ABL
11.17.1 ABL Company Details
11.17.2 ABL Business Overview
11.17.3 ABL Cell and Gene Therapy Manufacturing Services Introduction
11.17.4 ABL Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.17.5 ABL Recent Developments
11.18 Resilience
11.18.1 Resilience Company Details
11.18.2 Resilience Business Overview
11.18.3 Resilience Cell and Gene Therapy Manufacturing Services Introduction
11.18.4 Resilience Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.18.5 Resilience Recent Developments
11.19 BioCentriq
11.19.1 BioCentriq Company Details
11.19.2 BioCentriq Business Overview
11.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Introduction
11.19.4 BioCentriq Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.19.5 BioCentriq Recent Developments
11.20 Porton Biopharma Limited
11.20.1 Porton Biopharma Limited Company Details
11.20.2 Porton Biopharma Limited Business Overview
11.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Introduction
11.20.4 Porton Biopharma Limited Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.20.5 Porton Biopharma Limited Recent Developments
11.21 Andelyn Biosciences
11.21.1 Andelyn Biosciences Company Details
11.21.2 Andelyn Biosciences Business Overview
11.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Introduction
11.21.4 Andelyn Biosciences Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.21.5 Andelyn Biosciences Recent Developments
11.22 Commercializing Living Therapies
11.22.1 Commercializing Living Therapies Company Details
11.22.2 Commercializing Living Therapies Business Overview
11.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Introduction
11.22.4 Commercializing Living Therapies Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.22.5 Commercializing Living Therapies Recent Developments
11.23 Vibalogics
11.23.1 Vibalogics Company Details
11.23.2 Vibalogics Business Overview
11.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Introduction
11.23.4 Vibalogics Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.23.5 Vibalogics Recent Developments
11.24 Anemocyte Srl
11.24.1 Anemocyte Srl Company Details
11.24.2 Anemocyte Srl Business Overview
11.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Introduction
11.24.4 Anemocyte Srl Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.24.5 Anemocyte Srl Recent Developments
11.25 ElevateBio
11.25.1 ElevateBio Company Details
11.25.2 ElevateBio Business Overview
11.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Introduction
11.25.4 ElevateBio Revenue in Cell and Gene Therapy Manufacturing Services Business (2017-2022)
11.25.5 ElevateBio Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
